131 related articles for article (PubMed ID: 31870703)
1. The conflicting role of E2F1 in prostate cancer: A matter of cell context or interpretational flexibility?
Chun JN; Cho M; Park S; So I; Jeon JH
Biochim Biophys Acta Rev Cancer; 2020 Jan; 1873(1):188336. PubMed ID: 31870703
[TBL] [Abstract][Full Text] [Related]
2. TFDP3 was expressed in coordination with E2F1 to inhibit E2F1-mediated apoptosis in prostate cancer.
Ma Y; Xin Y; Li R; Wang Z; Yue Q; Xiao F; Hao X
Gene; 2014 Mar; 537(2):253-9. PubMed ID: 24406621
[TBL] [Abstract][Full Text] [Related]
3. Elevated E2F1 inhibits transcription of the androgen receptor in metastatic hormone-resistant prostate cancer.
Davis JN; Wojno KJ; Daignault S; Hofer MD; Kuefer R; Rubin MA; Day ML
Cancer Res; 2006 Dec; 66(24):11897-906. PubMed ID: 17178887
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of PDZ-binding kinase confers malignant phenotype in prostate cancer via the regulation of E2F1.
Chen JH; Liang YX; He HC; Chen JY; Lu JM; Chen G; Lin ZY; Fu X; Ling XH; Han ZD; Jiang FN; Zhong WD
Int J Biol Macromol; 2015 Nov; 81():615-23. PubMed ID: 26314905
[TBL] [Abstract][Full Text] [Related]
5. miR-449a enhances radiosensitivity through modulating pRb/E2F1 in prostate cancer cells.
Mao A; Liu Y; Wang Y; Zhao Q; Zhou X; Sun C; Di C; Si J; Gan L; Zhang H
Tumour Biol; 2016 Apr; 37(4):4831-40. PubMed ID: 26520443
[TBL] [Abstract][Full Text] [Related]
6. Differential impact of RB status on E2F1 reprogramming in human cancer.
McNair C; Xu K; Mandigo AC; Benelli M; Leiby B; Rodrigues D; Lindberg J; Gronberg H; Crespo M; De Laere B; Dirix L; Visakorpi T; Li F; Feng FY; de Bono J; Demichelis F; Rubin MA; Brown M; Knudsen KE
J Clin Invest; 2018 Jan; 128(1):341-358. PubMed ID: 29202480
[TBL] [Abstract][Full Text] [Related]
7. Transcription factor E2F1 is a potent transactivator of the insulin-like growth factor-I receptor (IGF-IR) gene.
Schayek H; Bentov I; Rotem I; Pasmanik-Chor M; Ginsberg D; Plymate SR; Werner H
Growth Horm IGF Res; 2010 Feb; 20(1):68-72. PubMed ID: 19703789
[TBL] [Abstract][Full Text] [Related]
8. E2F1 Induces tumor cell survival via nuclear factor-kappaB-dependent induction of EGR1 transcription in prostate cancer cells.
Zheng C; Ren Z; Wang H; Zhang W; Kalvakolanu DV; Tian Z; Xiao W
Cancer Res; 2009 Mar; 69(6):2324-31. PubMed ID: 19276347
[TBL] [Abstract][Full Text] [Related]
9. The E2F1/Rb and p53/MDM2 pathways in DNA repair and apoptosis: understanding the crosstalk to develop novel strategies for prostate cancer radiotherapy.
Udayakumar T; Shareef MM; Diaz DA; Ahmed MM; Pollack A
Semin Radiat Oncol; 2010 Oct; 20(4):258-66. PubMed ID: 20832018
[TBL] [Abstract][Full Text] [Related]
10. E2F1 promotes tumor cell invasion and migration through regulating CD147 in prostate cancer.
Liang YX; Lu JM; Mo RJ; He HC; Xie J; Jiang FN; Lin ZY; Chen YR; Wu YD; Luo HW; Luo Z; Zhong WD
Int J Oncol; 2016 Apr; 48(4):1650-8. PubMed ID: 26891801
[TBL] [Abstract][Full Text] [Related]
11. Novel Oncogenic Transcription Factor Cooperation in RB-Deficient Cancer.
Mandigo AC; Shafi AA; McCann JJ; Yuan W; Laufer TS; Bogdan D; Gallagher L; Dylgjeri E; Semenova G; Vasilevskaya IA; Schiewer MJ; McNair CM; de Bono JS; Knudsen KE
Cancer Res; 2022 Jan; 82(2):221-234. PubMed ID: 34625422
[TBL] [Abstract][Full Text] [Related]
12. LncRNA GAS5 Inhibits Cellular Proliferation by Targeting P27
Luo G; Liu D; Huang C; Wang M; Xiao X; Zeng F; Wang L; Jiang G
Mol Cancer Res; 2017 Jul; 15(7):789-799. PubMed ID: 28396462
[TBL] [Abstract][Full Text] [Related]
13. Icilin inhibits E2F1-mediated cell cycle regulatory programs in prostate cancer.
Lee S; Chun JN; Kim SH; So I; Jeon JH
Biochem Biophys Res Commun; 2013 Nov; 441(4):1005-10. PubMed ID: 24239550
[TBL] [Abstract][Full Text] [Related]
14. E2F1 induces TINCR transcriptional activity and accelerates gastric cancer progression via activation of TINCR/STAU1/CDKN2B signaling axis.
Xu TP; Wang YF; Xiong WL; Ma P; Wang WY; Chen WM; Huang MD; Xia R; Wang R; Zhang EB; Liu YW; De W; Shu YQ
Cell Death Dis; 2017 Jun; 8(6):e2837. PubMed ID: 28569791
[TBL] [Abstract][Full Text] [Related]
15. E2F1 enhances glycolysis through suppressing Sirt6 transcription in cancer cells.
Wu M; Seto E; Zhang J
Oncotarget; 2015 May; 6(13):11252-63. PubMed ID: 25816777
[TBL] [Abstract][Full Text] [Related]
16. [Effects of TFDP3 on regulating the autophagy and apoptosis of LNCaP cells].
Ren LF; Ma YY; Yue QH; Su MQ; Hao XK
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Apr; 28(4):347-9. PubMed ID: 22482402
[TBL] [Abstract][Full Text] [Related]
17. [Effect of transcription factor E2F1 expression on the invasion of prostate cancer].
Bi XC; Pu XY; Liu JM; Huang S
Zhonghua Yi Xue Za Zhi; 2017 Sep; 97(36):2856-2859. PubMed ID: 29050152
[No Abstract] [Full Text] [Related]
18. Cancer-testis specific gene OIP5: a downstream gene of E2F1 that promotes tumorigenesis and metastasis in glioblastoma by stabilizing E2F1 signaling.
He J; Zhao Y; Zhao E; Wang X; Dong Z; Chen Y; Yang L; Cui H
Neuro Oncol; 2018 Aug; 20(9):1173-1184. PubMed ID: 29547938
[TBL] [Abstract][Full Text] [Related]
19. E2F-1 targets miR-519d to regulate the expression of the ras homolog gene family member C.
Sang XB; Zong ZH; Wang LL; Wu DD; Chen S; Liu BL; Zhao Y
Oncotarget; 2017 Feb; 8(9):14777-14793. PubMed ID: 28146423
[TBL] [Abstract][Full Text] [Related]
20. RBM38 is a direct transcriptional target of E2F1 that limits E2F1-induced proliferation.
Feldstein O; Ben-Hamo R; Bashari D; Efroni S; Ginsberg D
Mol Cancer Res; 2012 Sep; 10(9):1169-77. PubMed ID: 22798430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]